Adipotide: A Novel Peptide Targeting Fat Cell Apoptosis for Obesity Research

Discover Adipotide (FTPP), a revolutionary peptide for targeted fat cell research and metabolic studies.

Get a Quote & Sample

Key Advantages

Targeted Fat Cell Disruption

Adipotide offers a precise method for targeting white adipose tissue, a key area of focus in obesity research, by disrupting its blood supply.

Metabolic Improvement Potential

Studies suggest Adipotide may lead to significant weight loss and improved insulin sensitivity, offering insights into metabolic disease models.

Novel Mechanism of Action

The unique FTPP homing sequence and prohibitin receptor targeting present a novel approach for understanding and potentially treating obesity.

Key Applications

Obesity Mechanism Studies

Utilize Adipotide to investigate the complex mechanisms behind obesity and fat accumulation in preclinical models.

Metabolic Disease Research

Adipotide research can shed light on its role in metabolic disorders, including type 2 diabetes, by studying its impact on fat tissue.

Targeted Therapeutics Development

The selective targeting of adipose tissue vasculature by Adipotide provides a foundation for developing novel fat-reduction therapies.

Comparative Therapeutic Evaluation

Researchers can evaluate Adipotide against conventional weight-loss approaches to understand its efficacy and potential.